SCHEMBL3740875

SCHEMBL3740875

CN(C)CCNCCC(=O)N1CC[N]CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
PAOX Q6QHF9 1/20 0.36
NPC1 O15118 2/20 0.35
ACKR3 P25106 1/20 0.34
ALDH1A1 P00352 3/20 0.33
NAMPT P43490 1/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
ATM Q13315 1/20 0.32
KDM4E B2RXH2 1/20 0.32
USP2 O75604 1/20 0.32
LMNA P02545 1/20 0.32
CYP3A4 P08684 1/20 0.32
HPGD P15428 1/20 0.32
HSD17B10 Q99714 1/20 0.32
EPHX2 P34913 1/20 0.32
ANPEP P15144 1/20 0.32
DNM1 Q05193 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2481091 0.83 NPC1 (0.41) NPC1ACKR3ALDH1A1NAMPTMEN1
SCHEMBL3741054 0.81 ALDH1A1 (0.35) NPC1ALDH1A1MEN1KMT2ATDP1
SCHEMBL13043912 0.80 HRH3 (0.42) PAOXACKR3ALDH1A1KDM4EL3MBTL1
SCHEMBL3736530 0.80 NPC1 (0.47) NPC1ALDH1A1MEN1KMT2ATDP1
SCHEMBL3732338 0.78 ALDH1A1 (0.38) NPC1ALDH1A1MEN1KMT2ATDP1
SCHEMBL13043918 0.72 PAOX (0.44) PAOXNPC1ALDH1A1MEN1KMT2A
SCHEMBL4143426 0.71 L3MBTL1 (0.48) NPC1ALDH1A1MEN1KMT2ATDP1
SCHEMBL4249 0.71 KDM4E (0.41) NPC1ALDH1A1MEN1KMT2ATDP1
SCHEMBL3551854 0.69 TDP1 (0.43) NPC1ALDH1A1MEN1KMT2ATDP1
SCHEMBL29256117 0.69 CYP2C9 (0.48) CYP2C9CYP2C19PAOXALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7829567-B2 Imino-indeno[1,2-c] quinoline derivatives, their preparation processes, and pharmaceutical compositions comprising the same KAOHSIUNG MEDICAL UNIVERSITY (TW) 2010-11-09 US claimed
US-7829567-B2 Imino-indeno[1,2-c] quinoline derivatives, their preparation processes, and pharmaceutical compositions comprising the same KAOHSIUNG MEDICAL UNIVERSITY (TW) 2010-11-09 US disclosed
US-20090111987-A1 Imino-Indeno[1,2-c] quinoline derivatives, their preparation processes, and pharmaceutical compositions comprising the same KAOHSIUNG MEDICAL UNIVERSITY (TW) 2009-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090111987-A1 Imino-Indeno[1,2-c] quinoline derivatives, their preparation processes, and pharmaceutical compositions comprising the same IMPA1, IMPDH1, IPO5 CYP2C9 130/4885CYP2C19 173/4885PAOX 3546/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.